Casey Ross
Nurse Practitioner · Lubbock, TXNPI 1649523861
Payments from drug & device makers
Across 179 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$638
- Biohaven Pharmaceuticals, Inc.$342
- Novo Nordisk$211
- Clarus Therapeutics Inc.$199
- Arbor Pharmaceuticals, Inc.$152
- Eisai Inc.$129
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,739100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $638 |
| Biohaven Pharmaceuticals, Inc. | 16 | $342 |
| Novo Nordisk | 15 | $211 |
| Clarus Therapeutics Inc. | 11 | $199 |
| Arbor Pharmaceuticals, Inc. | 9 | $152 |
| Eisai Inc. | 8 | $129 |
| Amarin Pharma, Inc. | 7 | $116 |
| Optinose US, Inc. | 5 | $95 |
| Genentech USA, Inc. | 5 | $85 |
| Merck | 5 | $82 |
| GSK | 5 | $77 |
| Esperion Therapeutics, Inc. | 3 | $65 |
| Amneal Pharmaceuticals LLC | 3 | $58 |
| Amgen | 4 | $57 |
| Lilly USA, LLC | 4 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Currax Pharmaceuticals LLC | 3 | $44 |
| Virtus Pharmaceuticals LLC | 2 | $37 |
| Boston Scientific | 1 | $36 |
| Abbott | 2 | $31 |
| Novartis | 2 | $26 |
| Boehringer Ingelheim | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
| Aytu Biopharma, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Neos Therapeutics, LP | 1 | $15 |
| AstraZeneca | 1 | $11 |
How this compares
$2,739 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $557 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $411 |
| Cefdinir | 13 | $312 |
| Azelastine Hcl | 12 | $236 |
| Fluticasone Propionate | 27 | $216 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $169 |
| Levocetirizine Dihydrochloride | 11 | $122 |
| Azithromycin | 23 | $116 |
| Doxycycline Hyclate | 11 | $100 |
| Methylprednisolone | 15 | $68 |
| Prednisone | 38 | $33 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Lubbock
- Heather SullivanLubbock$28K
- Marygrace JohnsonLubbock$15K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.